000 01182 a2200337 4500
005 20250512064026.0
264 0 _c19871116
008 198711s 0 0 eng d
022 _a0361-7742
040 _aNLM
_beng
_cNLM
100 1 _aDroz, J P
245 0 0 _aPhase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate.
_h[electronic resource]
260 _bProgress in clinical and biological research
_c1987
300 _a235-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Evaluation
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProstatic Neoplasms
_xdrug therapy
700 1 _aFargeot, P
700 1 _aLaplaige, P
700 1 _aMoran-Ribon, A
700 1 _aPiot, G
773 0 _tProgress in clinical and biological research
_gvol. 243B
_gp. 235-42
999 _c3664724
_d3664724